{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:32:36Z","timestamp":1778394756234,"version":"3.51.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Macrophage\u2212related genes (MRGs), a group of pivotal regulators governing macrophage differentiation, polarization, and function, have increasingly been recognized as critical modulators in tumor progression and immune evasion. However, the molecular expression profiles of MRGs and their intricate relationships with the immune microenvironment in breast cancer (BRCA) remain insufficiently investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We first used bulk RNA sequencing and single-cell RNA sequencing data from the TCGA and GEO databases, we analyzed the molecular expression patterns and clinical relevance of MRGs in BRCA. A prognostic model was developed using these genes, and the variations in the immune microenvironment between the high-risk and low-risk groups were evaluated. Additionally, the model\u2019s predictive ability for immunotherapy response was assessed. Finally, we conducted\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments to study the biological functions of HAGHL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multi-omics analysis identified a group of MRGs with prognostic value, leading to the successful development of a model that stratified BRCA patients into high- and low-risk categories. The model demonstrated high accuracy in predicting patient survival. Immune microenvironment-related analysis revealed significant differences between risk groups, and the model effectively predicted responses to immunotherapy. CellChat analysis suggested potential macrophage pathways in BRCA. Our results also show that HAGHL, as a carcinogenic factor in BRCA, knockdown can inhibit the proliferation and invasion of BRCA cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed a prognostic model based on MRGs, which holds promise for predicting outcomes in BRCA patients and responses to immunotherapy. Our findings offer new insights and potential guidance for personalized treatment strategies in BRCA. Additionally, we identified HAGHL as a potential oncogene, laying the groundwork for future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1776875","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:36:46Z","timestamp":1774507006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage-associated prognostic modeling uncovers immunotherapy response mechanisms and defines HAGHL as a novel oncogenic driver in breast cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Shengbin","family":"Pei","sequence":"first","affiliation":[{"name":"Department of Breast Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Nanjing Medical University Affiliated Suzhou Hospital: Suzhou Municipal Hospital, Gusu School, Nanjing Medical University","place":["Suzhou, China"]},{"name":"Department of Breast and Thyroid Surgery, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, People\u2019s Hospital of Pingshun County","place":["Changzhi, Shanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luxiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazhe","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Nanjing Medical University Affiliated Suzhou Hospital: Suzhou Municipal Hospital, Gusu School, Nanjing Medical University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e70020","DOI":"10.1002\/cai2.70020","article-title":"Global trajectories of colorectal cancer burden from 1990 to 2021 and projection to 2040","volume":"4","author":"Chen","year":"2025","journal-title":"Cancer Innov"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.70016","article-title":"Global, regional, and national burden of breast cancer in adolescents and young adults aged 15\u201339 years from 1990 to 2021 based on the global burden of disease study 2021","volume":"4","author":"Qu","year":"2025","journal-title":"Cancer Innov"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e70032","DOI":"10.1002\/cai2.70032","article-title":"Guidelines for the diagnosis and treatment of advanced breast cancer in China (2024 edition)","volume":"4","year":"2025","journal-title":"Cancer Innov"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1021\/acs.jmedchem.5c02586","article-title":"Coupling pd-L1 inhibition and lysosomal degradation: innovative anti-pd-L1 peptides for nsclc immunotherapy","volume":"69","author":"Merlino","year":"2026","journal-title":"J Med Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218330","article-title":"Protein kinase C\u03b9-driven macrophage infiltration mediates immunosuppression in non-small cell lung cancer","volume":"644","author":"Hu","year":"2026","journal-title":"Cancer Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.70018","article-title":"Advances in cellular immune theranostic approaches for glioblastoma: current trends and future directions","volume":"4","author":"Gong","year":"2025","journal-title":"Cancer Innov"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3390\/life13051189","article-title":"Progress and challenges of immunotherapy predictive biomarkers for triple negative breast cancer in the era of single-cell multi-omics","volume":"13","author":"Yu","year":"2023","journal-title":"Life (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"218350","DOI":"10.1016\/j.canlet.2026.218350","article-title":"Reprogramming the immune microenvironment in triple-negative breast cancer with mrna therapeutics","volume":"645","author":"Verma","year":"2026","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40164-025-00667-y","article-title":"Immunotherapy in breast cancer: current landscape and emerging trends","volume":"14","author":"Ran","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102529","article-title":"Macrophage efferocytosis mediated by the tp63-rac2 pathway promotes immunosuppressive remodeling in esophageal cancer","volume":"7","author":"Xi","year":"2026","journal-title":"Cell Rep Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.70023","article-title":"Epi-immunotherapy in cancer treatment: mechanisms, clinical progress, and future directions","volume":"4","author":"Lu","year":"2025","journal-title":"Cancer Innov"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1524560","article-title":"Combining single-cell analysis and molecular docking techniques to construct a prognostic model for colon adenocarcinoma and uncovering inhibin subunit \u03b2b as a novel therapeutic target","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.10.004","article-title":"Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis","volume":"44","author":"Rodr\u00edguez-Morales","year":"2023","journal-title":"Trends Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1675292","article-title":"Bioinformatics identification of mitochondria and macrophage polarization-related genes in copd and their potential mechanisms","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","article-title":"Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment","volume":"12","author":"Zhang","year":"2024","journal-title":"biomark Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.3390\/ijms252212223","article-title":"Metabolic reprogramming of immune cells in the tumor microenvironment","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15751","article-title":"Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes","volume":"114","author":"Komohara","year":"2023","journal-title":"Cancer Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01786-6","article-title":"Progranulin induces immune escape in breast cancer via up-regulating pd-L1 expression on tumor-associated macrophages (Tams) and promoting cd8(+) T cell exclusion","volume":"40","author":"Fang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1489444","article-title":"Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer","volume":"15","author":"Ding","year":"2024","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7053","article-title":"Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer","volume":"13","author":"Elfstrum","year":"2024","journal-title":"Cancer Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2024.0222","article-title":"Evolving molecular subtyping of breast cancer advances precision treatment","volume":"21","author":"Shan","year":"2024","journal-title":"Cancer Biol Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217967","article-title":"Prmt2 promotes tumorigenic phenotypes through the wnt signaling pathway and drives immune suppression in colorectal cancer","volume":"632","author":"Zou","year":"2025","journal-title":"Cancer Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.125","article-title":"Identification of collagen subtypes of gastric cancer for distinguishing patient prognosis and therapeutic response","volume":"3","author":"Wang","year":"2024","journal-title":"Cancer Innov"},{"key":"B34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-025-03432-5","article-title":"Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts","volume":"44","author":"Lin","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"218348","DOI":"10.1016\/j.canlet.2026.218348","article-title":"Mif-cd74 axis facilitates mdsc infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma","volume":"645","author":"Fukuda","year":"2026","journal-title":"Cancer Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1690301","article-title":"Integrative multidimensional analysis of age-associated synthetic lethal genes and development of a prognostic model in breast cancer","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13058-025-02022-9","article-title":"Dissecting the tumor microenvironment in primary breast angiosarcoma: insights from single-cell rna sequencing","volume":"27","author":"Ding","year":"2025","journal-title":"Breast Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41698-025-01097-z","article-title":"Pan cancer research reveals the role of ptgds in tumor suppression and immune regulation","volume":"9","author":"Li","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218168","article-title":"A two-stage genome-wide association study to identify novel genetic loci associated with iraes in lung cancer patients receiving pd-1\/pd-L1 inhibitors","volume":"639","author":"She","year":"2026","journal-title":"Cancer Lett"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.122","article-title":"Identification of nr3c2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer","volume":"3","author":"Sun","year":"2024","journal-title":"Cancer Innov"},{"key":"B41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"Pd-1\/pd-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216182","article-title":"Immune-checkpoint inhibitor resistance in cancer treatment: current progress and future directions","volume":"562","author":"Zhang","year":"2023","journal-title":"Cancer Lett"},{"key":"B44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-trna synthetase, aars1, is a lactate sensor and lactyltransferase that lactylates P53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci177606","article-title":"Pharmacologic ldh inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models","volume":"134","author":"Verma","year":"2024","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406333","article-title":"Lactylated apolipoprotein C-ii induces immunotherapy resistance by promoting extracellular lipolysis","volume":"11","author":"Chen","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114957","article-title":"H3k9 lactylation in Malignant cells facilitates cd8(+) T cell dysfunction and poor immunotherapy response","volume":"43","author":"Wang","year":"2024","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-03008-1","article-title":"Identification of haghl as a novel metabolic oncogene regulating human colorectal cancer progression","volume":"25","author":"Xu","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101888","article-title":"Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation","volume":"81","author":"Trujillo","year":"2024","journal-title":"Mol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204812","article-title":"Significance of liquid-liquid phase separation (Llps)-related genes in breast cancer: A multi-omics analysis","volume":"15","author":"Xie","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-4066","article-title":"Molecular characterization and classification of her2-positive breast cancer inform tailored therapeutic strategies","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011036","article-title":"Ectopic expression of gdf15 in cancer-associated fibroblasts enhances melanoma immunosuppression via the gfral\/ret cascade","volume":"13","author":"Zhao","year":"2025","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1776875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:36:47Z","timestamp":1774507007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1776875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2026.1776875"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1776875","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"1776875"}}